ONGLYZA DIABETES MEDICATION
OVERVIEW OF ONGLYZA LAWSUIT
The FDA has issued warnings, and studies have shown that the Type II Diabetes drugs Onglyza, also known as Saxagliptin or Kombiglyze, have been reported to increase the risk of Heart Failure and Congestive Heart Failure. Porter Malouf, P.A. is currently filing an Onglyza lawsuit against the manufacturer of Onglyza, Saxagliptin, and Kombiglyze. If you have experienced fluid retention, heart failure, or congestive heart failure after taking Onglyza, Saxagliptin, or Kombiglyze, or if you have a loved one who has died as a result of heart failure or congestive heart failure after taking these drugs, then please contact us immediately to file your claim.
There are two types of possible Onglyza lawsuits. The first type of Onglyza lawsuit seeks compensation for injury losses. This includes, but is not limited to, lost wages, pain and suffering, and/or medical bills. The second type of Onglyza lawsuit is a wrongful death claim. These are filed by family and loved ones of a person who allegedly died from taking Onglyza.